Benzinga··PrnewswireOrexo Restructures Leadership to Pivot Toward Drug Development After Zubsolv Sale
Orexo restructures leadership and divests Zubsolv to focus on drug development and AmorphOX technology advancement.
ORXOYproduct developmentorganizational restructuring